Psychedelic-assisted therapy is an emerging form of treatment that combines the use of psychedelic substances with structured psychological support, including preparation before the experience and integration afterward. The goal is not simply to have a powerful experience, but to help a person make meaning of it and translate insights into lasting change in daily life.
This article is educational and not a substitute for therapy, medical care, or crisis services.
If reading this brings up intense distress, flashbacks, dissociation, or urges to harm yourself, please pause and reach out to a qualified mental health professional or crisis resource in your area.
What psychedelic-assisted therapy is
Psychedelic-assisted therapy involves the supervised use of substances such as psilocybin, MDMA, or ketamine in combination with psychotherapy. The psychedelic experience is framed as a catalyst for exploration, not a cure in itself.
A typical clinical model includes three phases: preparation, the dosing session, and integration. Preparation helps a person understand what to expect, build trust with the facilitators, and clarify intentions. The dosing session provides the psychedelic experience in a safe, monitored setting. Integration sessions follow, where the person reflects on what came up and explores how to apply insights to everyday life.
Psychedelic-assisted therapy is currently being studied for a range of conditions, including depression, treatment-resistant depression, PTSD, anxiety related to serious illness, and substance use disorders. Research is still developing, and access through legal clinical settings varies by country and jurisdiction.
What integration means
Integration is the process of revisiting and actively engaging with the content of a psychedelic experience in order to make sense of it, work through it, and incorporate its lessons into daily life. It is not a single event but an ongoing process that unfolds over days, weeks, or months.
Integration can involve:
- Reflecting on what was seen, felt, or understood during the experience.
- Working through difficult emotions, memories, or realizations that surfaced.
- Identifying practical changes that support well-being, such as new habits, boundaries, or ways of relating.
- Exploring how insights connect to existing patterns, relationships, and beliefs.
- Finding language for experiences that may feel hard to describe.
In formal psychedelic-assisted therapy trials, each dosing session is often followed by several dedicated integration sessions spread over subsequent weeks. This structure reflects the understanding that the experience itself is only part of the therapeutic process.
Why integration matters
Psychedelic experiences can be profound, confusing, or emotionally intense. Without support, insights can fade, be misinterpreted, or lead to confusion rather than growth.
Integration helps bridge the gap between the altered state and ordinary waking life. It supports the person in translating what was experienced into something usable, such as a new perspective on a relationship, a deeper understanding of a trauma pattern, or a renewed sense of purpose.
Research on integration is still emerging, but clinical practice increasingly recognizes it as a core component of safe and effective psychedelic-assisted therapy. A recent review of integration in classic psychedelic-assisted therapies highlights the need for best-practice guidelines to support clinical translation and replication.
What integration may look like
Integration practices vary by person and setting, but many share common elements.
Reflection and journaling
Writing about the experience soon after it occurs can help capture details that might otherwise fade. Journaling can include descriptions of imagery, emotions, insights, memories, and bodily sensations.
Talking with a therapist or facilitator
Structured integration sessions with a trained therapist or facilitator provide a space to process the experience in a supported way. The therapist helps the person stay grounded, explore meaning, and connect insights to real-life patterns.
Somatic practices
Because psychedelic experiences often involve strong bodily sensations, somatic approaches can be especially useful in integration. Practices such as breath awareness, gentle movement, grounding, and body scanning help a person stay connected to the present and regulate activation that may still be present after the experience.
For a broader introduction to body-centered approaches that can support integration, see Embodywise’s Somatic Therapy overview.
Creative expression
Art, music, movement, or other creative outlets can help process material that is difficult to put into words. These practices allow the person to engage with the experience through a different channel.
Community and peer support
Some people find value in sharing their experience with trusted friends, support groups, or integration circles. This can reduce isolation and provide multiple perspectives on what came up.
Lifestyle changes
Integration often involves practical changes. A person may decide to address a difficult relationship, adjust daily routines, seek additional therapy, or make space for practices that support ongoing well-being.
The role of the body in integration
Psychedelic experiences frequently involve intense physical sensations, such as warmth, pressure, trembling, or waves of energy. These sensations can carry emotional meaning and may connect to trauma patterns or unprocessed experiences.
Somatic integration helps a person stay with these sensations without becoming overwhelmed. By tracking the body with curiosity and care, the person can allow the nervous system to complete unfinished responses and settle into a more regulated state.
In our somatic and Hakomi-informed work, we often observe that when a person can stay present with a strong bodily sensation from a psychedelic experience, rather than pushing it away or analyzing it too quickly, the nervous system settles more fully and insights feel more embodied. This kind of embodied processing supports deeper and more lasting integration.
Psychedelic-assisted therapy and trauma
Psychedelic-assisted therapy is being studied as a treatment for trauma-related conditions, including PTSD. Early research suggests that psychedelics may help people access and process traumatic material in ways that traditional talk therapy alone sometimes cannot.
However, trauma work with psychedelics requires careful screening, preparation, and skilled facilitation. Not everyone is a good candidate, and some people may experience increased anxiety, destabilization, or reactivation of trauma symptoms.
Integration is especially important in trauma-focused psychedelic work. It provides a container for processing what came up and for ensuring that the person does not feel left alone with intense material after the experience.
Current evidence and limitations
Research on psychedelic-assisted therapy is advancing rapidly, but it is still an evolving field.
- A recent narrative review found that psilocybin-assisted therapy shows meaningful antidepressant effects, with strongest evidence in major depressive disorder and treatment-resistant depression, and preliminary support in PTSD.
- A 52-week follow-up study reported dose-dependent maintenance of antidepressant benefit after a single 25 mg psilocybin session.
- A pilot study in veterans with severe treatment-resistant depression reported a 60% response rate at three weeks.
- A living review of 15 randomized trials confirmed a meaningful antidepressant effect while identifying functional unblinding as a substantial threat to effect estimates.
Despite promising results, several limitations remain. Many studies have small sample sizes, and the psychedelic experience itself can make blinding difficult, which complicates interpretation of results. More research is needed to establish long-term safety, optimal dosing, and the specific role of integration in outcomes.
Safety and ethical considerations
Psychedelic-assisted therapy carries real risks and requires careful attention to safety.
- Screening. Not everyone is a suitable candidate. People with certain psychiatric conditions, such as a personal or family history of psychosis, may be at higher risk.
- Legal status. The legal status of psychedelic substances varies widely by country and region. In many places, psilocybin and MDMA remain controlled substances outside of approved research or clinical settings.
- Facilitator qualifications. The skill and training of the person guiding the experience matter greatly. Look for licensed professionals with specific training in psychedelic-assisted therapy and integration.
- Informed consent. Participants should understand the risks, benefits, and uncertainties involved before agreeing to participate.
- Ongoing support. Integration should not be an afterthought. It is a core part of ethical psychedelic-assisted therapy.
If you are considering psychedelic-assisted therapy, it is important to work within legal and clinical frameworks and to prioritize providers who emphasize safety, consent, and integration.
Who may benefit
Psychedelic-assisted therapy is being studied for people with:
- Major depressive disorder and treatment-resistant depression
- PTSD and trauma-related conditions
- Anxiety related to serious or terminal illness
- Substance use disorders, including alcohol and methamphetamine use disorder
- End-of-life distress and existential concerns
It is not appropriate for everyone. Screening, preparation, and integration are essential parts of determining whether this approach is a good fit for a particular person.
Finding support
If you are exploring psychedelic-assisted therapy, look for providers who offer:
- Clear screening and preparation processes
- Trained and licensed facilitators
- Structured integration sessions after the experience
- Transparency about risks, benefits, and legal status
- A trauma-informed and culturally sensitive approach
For practitioners who want to deepen their capacity to support integration through body-centered methods, Embodywise’s Hakomi Overview, Trainings and Workshops page describes mindful, somatic psychotherapy training that can complement psychedelic integration work.
Sources
- Bathje, G. J., Majdak, E., & Rezaei, S. (2022). Psychedelic integration: An analysis of the concept and its practice. Frontiers in Psychology, 13, 824077. https://pmc.ncbi.nlm.nih.gov/articles/PMC9386447/
- Rucker, J. J. H., et al. (2021). Psychedelic-Assisted Therapy: Emerging treatments in mental health disorders. Frontiers in Psychology, 12, 719399. https://pmc.ncbi.nlm.nih.gov/articles/PMC8574982/
- Majdak, P., et al. (2024). Deepening Psychedelic Integration: Exploring Complex Settings. In Progress in Brain Research. Springer. https://link.springer.com/chapter/10.1007/7854_2024_532
- Lau, C., et al. (2022). Integration in Psychedelic-Assisted Treatments: Recurring Definitions, Challenges, and Concerns. Journal of Humanistic Psychology. https://journals.sagepub.com/doi/10.1177/00221678221085800
- ScienceDirect. (2026). Integration in classic psychedelic-assisted therapies for mental health conditions: A systematic review. https://www.sciencedirect.com/science/article/pii/S2950484826000238
- ScienceDirect. (2026). Integrating consciousness, culture, and clinical practice: A review of psychedelic therapy. https://www.sciencedirect.com/science/article/pii/S2589979126000028
- University of California, San Francisco. Psilocybin Clinical Trials for 2026. https://clinicaltrials.ucsf.edu/psilocybin
- University of California Health. Psilocybin clinical trials. https://clinicaltrials.ucbraid.org/psilocybin
- MDPI. (2026). Psilocybin-Assisted Therapy in Psychiatry: A Narrative Review. Journal of Clinical Medicine, 15(16), 6228. https://www.mdpi.com/2077-0383/15/16/6228
- Embodywise. Understanding Somatic Therapy: Techniques, Benefits and Uses. https://embodywise.com/somatic-therapy-how-it-works-uses-types-and-techniques/
- Embodywise. Hakomi Overview, Trainings and Workshops. https://embodywise.com/hakomi-overview/